Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-203 vs Mucosta in Acute or Chronic Gastritis
NCT04066530Phase 3Completed
- Sponsor
- Addpharma, Inc.
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AD-203 in acute gastritis, chronic gastritis, sponsored by Addpharma, Inc.. Started Sep 2019; status: completed.
02
Drugs
AD-203
03
Conditions
acute gastritischronic gastritis
Beyond the preview
Go deeper on NCT04066530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066530.